---
f_date: '2020-07-30T00:00:00.000Z'
f_excerpt: >-
  In July 2020, three months into the pandemic, and in response to a case filed
  by American College of Obstetrics and Gynecologists (ACOG) and other
  organizations, a federal court blocked FDA’s enforcement of a restriction that
  requires the in-person dispensing of mifepristone.
title: ACOG Statement on Mailing Abortion Pills
slug: acog-statement-on-mailing
f_thumb:
  url: /assets/external/5fa312d468ff8ab773faedb2_press-dev-acog.jpg
  alt: null
f_category:
  - cms/media-categories/developments.md
  - cms/media-categories/press.md
f_posted-by: cms/author/plan-c.md
updated-on: '2020-11-17T17:38:11.391Z'
created-on: '2020-11-04T20:45:10.287Z'
published-on: '2020-11-18T18:16:53.001Z'
f_tags:
  - cms/media-tags/telemedicine.md
f_include-in-latest-developments-on-providers-page: true
f_source-url: >-
  https://www.acog.org/news/news-articles/2020/07/courts-order-lifting-burdensome-fda-restriction-what-you-need-to-know
layout: '[press].html'
tags: press
---

In July 2020, three months into the pandemic, and [in response to a case filed by American College of Obstetrics and Gynecologists (ACOG)](https://www.acog.org/news/news-articles/2020/07/courts-order-lifting-burdensome-fda-restriction-what-you-need-to-know) and other organizations, a federal court blocked FDA’s enforcement of a restriction that requires the in-person dispensing of mifepristone.
